XML 68 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation - Share-Based Compensation Amounts Included in Net Income (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Total compensation expense $ 1,150 $ 1,306 $ 4,705 $ 4,620  
Less: tax benefit (297) (339) (1,214) (1,200)  
Share-Based Compensation amounts included in net income $ 853 967 $ 3,491 3,420  
Awards to non-employee directors [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 526   652    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 130.36    
Total compensation expense $ 252 201 $ 706 581  
Award to key employees [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 204,563   204,563   197,398
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     67,458    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period     60,850    
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period     557    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 103.01   $ 103.01   $ 94.15
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     118.85    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value     90.60    
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expirations Weighted Average Grant Date Fair Value     $ 91.42    
Total compensation expense $ 898 $ 1,105 $ 3,999 $ 4,039